Venn Life Sciences Holdings PLC Issue of Equity (9163A)
29 March 2017 - 11:57PM
UK Regulatory
TIDMVENN
RNS Number : 9163A
Venn Life Sciences Holdings PLC
29 March 2017
29 March 2017
Venn Life Sciences Holdings Plc
("Venn" or the "Company")
Issue of Equity
Venn Life Sciences (AIM: VENN), a growing Contract Research
Organisation (CRO) providing drug development, clinical trial
management and resourcing solutions to pharmaceutical,
biotechnology and medical device clients, announces that an
application has been made by the Company to the London Stock
Exchange and the Irish Stock Exchange for 45,000 new ordinary
shares of nominal value of GBP0.001 each in the Company ("Ordinary
Shares") to be admitted to trading on the AIM market of the London
Stock Exchange and the ESM market of the Irish Stock Exchange. The
new Ordinary Shares will rank in pari passu with the existing
Ordinary Shares in issue.
The new Ordinary Shares are being issued in consideration of
services rendered to the Company during 2016. Dealings are expected
to commence in these new Ordinary Shares on at 8:00 a.m. on 4 April
2017.
Following admission of these new Ordinary Shares, Venn's issued
share capital will consist of 60,284,263 Ordinary Shares.
Enquiries:
Venn Life Sciences Holdings Plc
Allan Wood, Non-Executive Chairman
Tony Richardson, Chief Executive Officer Tel: +353 1 5499341
Davy (Nominated Adviser and Broker)
Fergal Meegan / Matthew de Vere Tel: +353 1 679 6363
White (Corporate Finance)
Orla Bolger (Corporate Broking)
Hybridan LLP (Co-Broker) Tel: +44 (0)20 3764 2341
Claire Louise Noyce
Walbrook PR Ltd Tel: +44(0)20 7933 8787
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOESEIFEUFWSEID
(END) Dow Jones Newswires
March 29, 2017 08:57 ET (12:57 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024